Global prevalence of human intestinal carriage of ESBL-producing <i>E. coli</i> during and after the COVID-19 pandemic.

JAC Antimicrob Resist · 2025 · PMC11759295 · PMID 39866328

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

8 In contrast, our study showed a trend of further increase in the pooled prevalence of ESBL E. coli in both community and healthcare settings.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.